Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 4Gastrointestinal 2Dermatologic 2Gynecologic 1Genitourinary 1Endocrine 1Breast 1

Conditions

Ovarian Neoplasms 815Uterine Cervical Neoplasms 549Endometrial Neoplasms 467Breast Neoplasms 227Fallopian Tube Neoplasms 202Colorectal Neoplasms 182Carcinoma, Non-Small-Cell Lung 163Neoplasms 140Stomach Neoplasms 128Pancreatic Neoplasms 120Prostatic Neoplasms 109Melanoma 108Neoplasm Metastasis 107Lung Neoplasms 105Carcinoma, Ovarian Epithelial 94Triple Negative Breast Neoplasms 92Squamous Cell Carcinoma of Head and Neck 82Esophageal Neoplasms 78Head and Neck Neoplasms 77Carcinoma, Renal Cell 76Urinary Bladder Neoplasms 75Uterine Neoplasms 68Vulvar Neoplasms 66Colonic Neoplasms 60Uterine Cervical Dysplasia 59Peritoneal Neoplasms 59Carcinoma, Hepatocellular 59Sarcoma 53Carcinoma, Transitional Cell 49Papillomavirus Infections 47

Interventions

enzalutamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lethal Congenital Contracture Syndrome 2 × Gynecologic × 1 year × Clear all
NCT05057013 2025-08-11

A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours

Cancer Research UK

Phase 1/2 Active not recruiting
81 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Lethal Congenital Contracture Syndrome 2, Fibromatosis, Gingival, 2, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Prostatic Neoplasms, Castration-Resistant, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡